Plan an Assay Transfer Around Site Differences

A field application scientist gets pulled into an assay transfer expecting a technical handoff and then finds out the real work is managing expectations across two sites that are never truly identical. The receiving lab wants a promise that its results will match the development lab exactly. You cannot make that promise, and if you fake it, the failure comes back to you months later when the numbers do not line up. This piece covers why the conversation gets tense, what to prepare before you have it, and how to talk through site differences without predicting an outcome you do not control.

Why This Conversation Goes Wrong

An assay moves from a development lab to a satellite site, and the receiving team assumes the method itself is the whole story. It is not. Equipment models differ. Software versions differ. Operators have different levels of hands on experience with the technique. Consumable lots come from different vendors or different manufacturing runs. Local procedures for storage, handling, and documentation were built for other assays and may not fit this one cleanly.

The customer often wants a single answer, will this work the same way here, because that answer lets them set a launch date and move on. You are the person in the room who understands the assay well enough to know that the answer is never a flat yes. When you hedge, it can sound like you are protecting yourself instead of protecting their data. When you overcommit to reassure them, you set up a validation failure that erodes trust far more than an honest answer would have. The tension in this conversation comes from that gap between what the customer wants to hear and what you can responsibly say.

There is also a role confusion problem. The field application scientist did not run the development validation and does not own the receiving site's local decisions. Your job is to surface the variables that matter, not to certify that the two sites will produce matching results. Losing sight of that distinction is where most of these conversations go sideways.

How To Prepare

Before you get on a call about a transfer, ask both sites to document their equipment, software versions, consumable handling practices, operator experience, and current procedures. Do this in writing, not verbally, because a written answer forces precision that a quick conversation does not.

Pay close attention to the receiving site's process for managing consumable lots. A site that has no defined process for tracking or qualifying incoming lots has a gap that will affect the transfer plan regardless of how well the method itself was written. If that answer is missing, treat it as an open item rather than filling in an assumption.

Know which approved instructions and technical resources actually apply to this transfer. Customers sometimes assume that any document with the assay's name on it is current or relevant, and pointing them to the correct version early avoids a slower correction later. Once you have identified the right resources, ask the customer directly who owns validation on their end and what their acceptance process looks like. Every site should have a named person responsible for signing off, and if they do not, that is worth raising before you set any dates.

Preparation also means understanding what has already been checked around the assay's physical environment. If the transfer involves automated liquid handling or a workcell, confirm that readiness separately, since a method can be scientifically sound and still fail because the surrounding equipment was never verified. The post on how to Assess Automation Workcell Readiness Before Discussing a Connection walks through that check in more detail, and it pairs naturally with an assay transfer conversation because the two issues get confused often.

Last, keep your own role clear in your head before the call starts. You are there to expose the variables, not to make the local call on whether results are acceptable. Write that boundary down if you need to, because it is easy to drift past it once a customer starts pressing for reassurance.

What To Say

Here is how this conversation plays out when the scope stays honest. An assay scientist on the customer side opens with the question everyone asks. She says, "Can you confirm our results will match what your development team saw?"

You answer without dodging the question or inflating it. You say, "I cannot confirm that outcome, because your site has its own equipment, its own operators, and its own consumable lots, and any of those can shift results even when the method is followed exactly. What I can do is walk you through the conditions your team needs to check, and we can use the approved instructions as the backbone of your local validation plan." Then you turn the conversation toward the open item you flagged earlier. You ask, "Has your satellite lead confirmed how you will manage consumable lot qualification for this assay?"

She pauses and admits that question has not been answered yet. Instead of glossing over it, you name the gap out loud. You say, "That needs an answer before we lock in a validation timeline, because lot to lot variability is one of the more common reasons a transferred assay looks different in a new lab." The group agrees to assign that question to the satellite lead before any dates get set.

Notice what did not happen in that exchange. You did not promise a match. You did not dismiss her question as unreasonable. You gave her a concrete next step and kept the decision about acceptance criteria with the people who actually own it on her side. That is the shape of a transfer conversation that holds up later, when the validation data comes in and someone asks who agreed to what.

Mistakes To Avoid

A few patterns show up again and again in these conversations, and each one creates a problem later even when it smooths things over in the moment.

1. Promising comparable results because the customer is anxious or the deal is close to closing. This feels helpful in the room and becomes a liability the moment the local validation shows a difference.

2. Treating the transfer as purely a documentation exercise. Handing over the same instructions used at the development site does not account for a different instrument model, a different reagent supplier, or a technician running the assay for the first time.

3. Letting the customer skip naming a validation owner. Without a named person accountable for the acceptance decision, disagreements about whether results are good enough have no clear resolution path.

4. Making the interpretation call yourself. Once your recommendations start reading as a scientific verdict on the customer's own data, you have stepped into a role that belongs to their lab, and that boundary is hard to walk back once crossed.

5. Setting a transfer date before the open questions are assigned. A date creates pressure to rush past unresolved items instead of resolving them, and that pressure is exactly what causes transfers to fail validation the first time through.

Avoiding these mistakes is less about scientific knowledge and more about discipline in how you frame each answer during the call.

How To Practice And Score It

A manager coaching a field application scientist on this conversation can build a simple exercise around it. Give the trainee two site profiles that differ in one operational detail, such as a different instrument model, and one training detail, such as an operator new to the technique. Ask the trainee to explain out loud why each difference belongs in the transfer discussion and what question it should generate.

Review their notes afterward for three things. Confirm they identified at least one validation step that the customer owns rather than one they tried to own themselves. Confirm they named a specific local decision maker instead of leaving acceptance vague. Confirm they made no predictions about how the eventual research results will turn out, since even a hedged prediction can get quoted back later as a promise.

DealSpeak's Biotechnology practice conversations give a field application scientist a place to run this exact scenario against an AI counterpart before facing it with a real customer, and the scoring highlights exactly where a trainee slipped into overpromising or lost track of who owns what. The same discipline about ownership shows up in adjacent conversations too, including how to Discuss a Backorder Against a Research Timeline With Accurate Ownershipwhere the core skill is again separating what you can commit to from what belongs to someone else's timeline.

Closing Thought

An assay transfer conversation goes well when you stay precise about what you can and cannot certify, and when you leave the room with a named owner attached to every open question. Practicing this exchange before it happens with a customer is what turns a scientist who freezes under pressure to reassure into one who calmly redirects the question toward the plan.